Business Description
Curis Inc
NAICS : 325414
SIC : 2836
ISIN : US2312692005
Description
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.4 | |||||
| Equity-to-Asset | -0.21 | |||||
| Debt-to-Equity | -0.37 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -43.22 | |||||
| Beneish M-Score | -3.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.8 | |||||
| 3-Year EBITDA Growth Rate | 5.6 | |||||
| 3-Year EPS without NRI Growth Rate | 9.8 | |||||
| 3-Year FCF Growth Rate | 12.5 | |||||
| 3-Year Book Growth Rate | -51.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 24.35 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.17 | |||||
| 9-Day RSI | 45.66 | |||||
| 14-Day RSI | 44.97 | |||||
| 3-1 Month Momentum % | -35.39 | |||||
| 6-1 Month Momentum % | -47.96 | |||||
| 12-1 Month Momentum % | -73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.22 | |||||
| Quick Ratio | 1.22 | |||||
| Cash Ratio | 0.95 | |||||
| Days Sales Outstanding | 94.78 | |||||
| Days Payable | 9889.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.8 | |||||
| Shareholder Yield % | -2.18 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 98.68 | |||||
| Operating Margin % | -465.42 | |||||
| Net Margin % | -443.35 | |||||
| FCF Margin % | -394.67 | |||||
| ROE % | -461.34 | |||||
| ROA % | -70.59 | |||||
| ROIC % | -215.22 | |||||
| 3-Year ROIIC % | 124.3 | |||||
| ROC (Joel Greenblatt) % | -1228.99 | |||||
| ROCE % | -92.49 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.87 | |||||
| EV-to-EBIT | -0.23 | |||||
| EV-to-EBITDA | -0.23 | |||||
| EV-to-Revenue | 1 | |||||
| EV-to-Forward-Revenue | 0.98 | |||||
| EV-to-FCF | -0.25 | |||||
| Price-to-GF-Value | 0.32 | |||||
| Price-to-Median-PS-Value | 0.22 | |||||
| Earnings Yield (Greenblatt) % | -434.78 | |||||
| FCF Yield % | -145.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CRIS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Curis Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 10.259 | ||
| EPS (TTM) ($) | -7.81 | ||
| Beta | 3.47 | ||
| 3-Year Sharpe Ratio | -0.29 | ||
| 3-Year Sortino Ratio | -0.57 | ||
| Volatility % | 75.54 | ||
| 14-Day RSI | 44.97 | ||
| 14-Day ATR ($) | 0.348994 | ||
| 20-Day SMA ($) | 3.342 | ||
| 12-1 Month Momentum % | -73 | ||
| 52-Week Range ($) | 2.86 - 17.49 | ||
| Shares Outstanding (Mil) | 8.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Curis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Curis Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Curis Inc Frequently Asked Questions
What is Curis Inc(CRIS)'s stock price today?
The current price of CRIS is $3.29. The 52 week high of CRIS is $17.49 and 52 week low is $2.86.
When is next earnings date of Curis Inc(CRIS)?
The next earnings date of Curis Inc(CRIS) is 2025-02-07 Est..
Does Curis Inc(CRIS) pay dividends? If so, how much?
Curis Inc(CRIS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers